| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/2001 | US6183758 Phytochemicals, nutrients & medication absorption &/or treatment |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183730 Antiperspirant and deodorant compositions containing cyclohexasiloxane |
| 02/06/2001 | US6183593 Curable blend |
| 02/06/2001 | US6183471 Spine distraction implant and method |
| 02/06/2001 | CA2314849A1 Topical composition comprising a tocopherol compound |
| 02/06/2001 | CA2314798A1 1,2,4,5-tetrahydro-benzo[d]azepin derivatives |
| 02/06/2001 | CA2220696C Improved method for controlling ectoparasites |
| 02/06/2001 | CA2217768C Flavorful zinc compositions for oral use incorporating copper |
| 02/06/2001 | CA2163032C Antibody fragments in therapy |
| 02/06/2001 | CA2147807C Bicyclic-aromatic compounds; pharmaceutical and cosmetic compositions containing them and uses |
| 02/06/2001 | CA2141572C Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 02/06/2001 | CA2126118C 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative |
| 02/06/2001 | CA2024789C Compounds for the treatment of inflammation and allergy |
| 02/05/2001 | CA2314867A1 2,7-substituted octahydro-1h-pyrido¬1,2-a|pyrazine derivatives as ligands for serotonin receptors |
| 02/03/2001 | CA2314746A1 Use of flupirtin for amelioration of pains in the degenerative joint diseases of dogs and cats |
| 02/01/2001 | WO2001007918A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | WO2001007914A1 Fenretinide increases antibody cellular toxicity |
| 02/01/2001 | WO2001007656A1 Antisense modulation of shp-1 expression |
| 02/01/2001 | WO2001007655A1 Antisense modulation of shp-2 expression |
| 02/01/2001 | WO2001007643A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating the drug effect of antimicrobial agent, and antimicrobial agents |
| 02/01/2001 | WO2001007637A2 Conditionally controlled, attenuated hiv vaccine |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007611A2 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | WO2001007602A2 Oligonucleotides for inhibiting the expression of human eg5 |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007594A1 Antisense modulation of mekk1 expression |
| 02/01/2001 | WO2001007486A1 A biodegradable polycation composition for delivery of an anionic macromolecule |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007462A1 11β-ARYL-17,17-SPIROTHIOLANE-SUBSTITUTED STEROIDS |
| 02/01/2001 | WO2001007461A1 Antisense modulation of mekk5 expression |
| 02/01/2001 | WO2001007457A1 Antisense modulation of pten expression |
| 02/01/2001 | WO2001007456A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
| 02/01/2001 | WO2001007455A1 Novel bicyclonucleoside analogues |
| 02/01/2001 | WO2001007454A1 Enzyme catalyzed therapeutic activation |
| 02/01/2001 | WO2001007453A1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration |
| 02/01/2001 | WO2001007441A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
| 02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | WO2001007436A2 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | WO2001007435A2 N-(indolcarbonyl-)piperazin derivatives als 5-ht2a-receptor ligands |
| 02/01/2001 | WO2001007434A2 Indole derivatives and their use as 5ht2a ligands |
| 02/01/2001 | WO2001007433A2 Quinoline derivatives and their use as antibacterial agents |
| 02/01/2001 | WO2001007432A2 Aminopiperidine derivatives as antibacterials |
| 02/01/2001 | WO2001007431A2 Benzothiophene derivatives |
| 02/01/2001 | WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 02/01/2001 | WO2001007418A2 Ceramide analogs, process for their preparation and their use as antitumor agents |
| 02/01/2001 | WO2001007417A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 02/01/2001 | WO2001007408A2 Novel method for preparing benzoperhydroisoindole compounds |
| 02/01/2001 | WO2001007405A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | WO2001007401A1 Tricyclic compounds and drug compositions containing the same |
| 02/01/2001 | WO2001007088A2 Methods for treating therapy-resistant tumors |
| 02/01/2001 | WO2001007087A2 Enzyme catalyzed anti-infective therapeutic agents |
| 02/01/2001 | WO2001007082A1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent |
| 02/01/2001 | WO2001007078A1 Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of medicament for the treatment of glycolipid storage diseases |
| 02/01/2001 | WO2001007069A1 In vivo induction for enhanced function of isolated hepatocytes |
| 02/01/2001 | WO2001007067A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | WO2001007066A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | WO2001007057A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | WO2001007056A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 02/01/2001 | WO2001007054A1 Methods for treating autoimmune diseases |
| 02/01/2001 | WO2001007053A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 02/01/2001 | WO2001007050A1 Nociceptin receptor orl-1 agonists for use in treating cough |
| 02/01/2001 | WO2001007049A2 Ophthalmic composition comprising ketotifen |
| 02/01/2001 | WO2001007047A2 Control of crustacean infestation of aquatic animals |
| 02/01/2001 | WO2001007043A1 Azetidine carboxamide derivatives for the treatment of cns disorders |
| 02/01/2001 | WO2001007041A1 Antiarrhythmic drug |
| 02/01/2001 | WO2001007040A1 Multidrug-resistant cancer overcoming agents and process for producing the same |
| 02/01/2001 | WO2001007039A2 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases |
| 02/01/2001 | WO2001007038A2 Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy |
| 02/01/2001 | WO2001007037A1 Method of treating symptoms of hormonal variation, including hot flashes |
| 02/01/2001 | WO2001007036A1 BICYCLIC ANTAGONISTS SELECTIVE FOR THE αvβ3 INTEGRIN |
| 02/01/2001 | WO2001007035A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 02/01/2001 | WO2001007034A1 Multidrug resistance pump inhibitors and uses thereof |
| 02/01/2001 | WO2001007033A2 Neuroprotective pharmaceutical reparations comprising p-fluoroselegiline |
| 02/01/2001 | WO2001007032A1 Th2 differentiation inhibitors |
| 02/01/2001 | WO2001007031A1 Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same |
| 02/01/2001 | WO2001007030A2 Compositions an inhibitor of an accrab-like efflux pump for reducung microbial resistance to drugs |
| 02/01/2001 | WO2001007029A2 Substituted guanidines and the use thereof |
| 02/01/2001 | WO2001007028A2 The use of retinoid receptor antagonists in the treatment of prostate carcinoma |
| 02/01/2001 | WO2001007027A2 Pyrimidine derivatives for the treatment of viral diseases |
| 02/01/2001 | WO2001007026A2 Improved method of treating type ii diabetes and obesity |
| 02/01/2001 | WO2001007025A2 Treatment of cardiac abnormalities with aryloxy propanolamines |
| 02/01/2001 | WO2001007024A2 Paracetamol and drotaverine containing composition |
| 02/01/2001 | WO2001007023A2 Azetidine compounds in cns and eye diseases |
| 02/01/2001 | WO2001007022A2 Azetidine compounds in cns and eye diseases |
| 02/01/2001 | WO2001007021A2 Process for the improvement of spermatozoa fertilization activity |
| 02/01/2001 | WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 02/01/2001 | WO2001007019A2 Use of n-acetyl-cysteine in the treatment of allergic pathologies of the respiratory tract |
| 02/01/2001 | WO2001007017A1 Transdermal therapeutic system for administering a calcium antagonist |
| 02/01/2001 | WO2001007015A2 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 02/01/2001 | WO2001007014A1 Formulations of steroid solutions for inhalatory administration |
| 02/01/2001 | WO2001006992A1 Use of salicylic acid for regulating hyperpigmented spots |
| 02/01/2001 | WO2001006991A1 Oil-in-water emulsion with improved stability |
| 02/01/2001 | WO2001006990A2 Use of etodolac to treat cancer |
| 02/01/2001 | WO2001006989A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | WO2001006987A2 Transnasal anticonvulsive compositions and modulated process |
| 02/01/2001 | WO2001006985A2 Select amino acids as zinc-solubilizing agents in anti-viral genital formulations |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2001006983A2 Fatty acids to minimize cancer therapy side effects |
| 02/01/2001 | WO2001006873A1 Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise |